Viewing Study NCT04234594


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-31 @ 11:50 AM
Study NCT ID: NCT04234594
Status: UNKNOWN
Last Update Posted: 2020-05-19
First Post: 2020-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module